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ABSTRACT: The influenza virus M2 amphipathic helix (M2AH)
alters membrane curvature in a cholesterol-dependent manner,
mediating viral membrane scission during influenza virus budding.
Here, we have investigated the biophysical effects of cholesterol on
the ability of an M2AH peptide to manipulate membrane properties.
We see that the ability of the M2AH to interact with membranes
and form an α-helix is independent of membrane cholesterol
concentration; however, cholesterol affects the angle of the M2AH
peptide within the membrane. This change in membrane orientation
affects the ability of the M2AH to alter lipid order. In low-
cholesterol membranes, the M2AH is inserted near the level of the
lipid head groups, increasing lipid order, which may contribute to
generation of the membrane curvature. As the cholesterol content increases, the M2AH insertion becomes flatter and slightly deeper
in the membrane below the lipid headgroups, where the polar face can continue to interact with the headgroups while the
hydrophobic face binds cholesterol. This changed orientation minimizes lipid packing defects and lipid order changes, likely reducing
the generation of membrane curvature. Thus, cholesterol regulates M2 membrane scission by precisely modulating M2AH
positioning within the membrane. This has implications for the understanding of many of amphipathic-helix-driven cellular budding
processes that occur in specific lipid environments.
■ INTRODUCTION
Influenza A viruses (IAV) assemble at and bud from
cholesterol- and sphingolipid-enriched lipid microdomains on
the apical plasma membrane of infected cells.1 The final step of
IAV budding is membrane scission, wherein the neck of the
budding virion is constricted to the point at which
spontaneous fusion of the opposing membranes can occur,
resulting in the release of the mature virion. The process of
IAV-membrane scission is mediated by the viral M2 protein,2
which is a 97 amino acid homotetrameric transmembrane
protein that has ion channel activity during virus entry.3−7
During virus budding, M2 is recruited to assembly sites
through interactions with the viral M1 matrix and hemag-
glutinin (HA) proteins, which recruit M2 to the periphery of
the lipid microdomains of assembling virus, placing M2 at the
lipid phase boundary between the lipid ordered virus budding
domain and the surrounding lipid disordered phase.8−11 The
ability of the M2 protein to mediate membrane scission is
dependent on the membrane insertion of a membrane-
proximal amphipathic helix (AH) domain.2,12,13 The M2AH
is 16 amino acids long and forms an α-helix upon association
with the membrane.2,14−17 Once formed, the AH contains
many bulky hydrophobic residues on one face and several
highly polar K/R residues on the opposite face. While these
polar residues likely interact with the polar lipid headgroups,
the hydrophobic face of the domain drives membrane
binding.17 The insertion of the AH domain causes membrane
scission, likely by altering membrane curvature.2,12,13 However,
the M2AH also senses membrane curvature, sorting to the
most highly curved region of the membrane neck, where it
increases membrane order, placing the membrane neck under
further strain and enhancing scission efficiency.11,18,19
Given that the M2 protein sorts to the sites of virus assembly
early in the budding process, before membrane scission,
regulatory mechanisms must be in place to prevent the early
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induction of membrane curvature and premature scission.1,20
One regulatory mechanism may be the weak nature of M2AH
curvature induction,18 such that the induction is only sufficient
to cause scission on a highly constricted membrane neck,
ensuring scission at the appropriate spatiotemporal location.
Importantly, M2AH mediation of membrane scission has been
shown to be dependent on its lipid environment, specifically
on the amount of surrounding membrane cholesterol.2 When
the local membrane cholesterol concentration is at 20−30
mol %, the ability of the M2AH to alter membrane curvature is
reduced and membrane scission is prevented.2 This activity is
restored when the cholesterol concentration is reduced below
15%. Several reports have shown that M2 can bind cholesterol,
and multiple potential binding sites have been proposed.21 It
was shown that the M2AH contains a cholesterol recognition
amino acid consensus (CRAC) domain and mutation of the
key Y52 residue reduced cholesterol association; however,
CRAC mutations did not affect M2 targeting to lipid raft
domains or virus budding.22,23 Conversely, mutation of the
M2AH palmitoylated residue C50 affected M2 raft targeting
but did not reduce M2 cholesterol association, as has been
shown for other palmitoylated proteins.22,24,25 In 2016, it was
predicted by solid-state NMR (ssNMR) experiments that the
M2 protein binds cholesterol through an interhelical crevice on
the outside of the tetrameric transmembrane domain (TMD)
and through bulky hydrophobic residues on the AH including
F54.26 Further ssNMR experiments refined this model,
showing that each M2 tetramer binds two cholesterol
molecules through hydrophobic interactions along the TMD
and through polar and aromatic interactions with F47 of the
AH and F57/R61 of the neighboring AH domain.27 These
experiments suggest that both the TMD and an isolated AH
domain have some capacity to interact with cholesterol
through specific interactions, although the interaction is likely
strongest in the context of the full-length protein. In the
context of the full-length protein, association with membrane
cholesterol appears to stabilize the AH and alter the
orientation of the AH domain in the membrane, although
the effects of this change on M2AH activity are not
known.28−30 In this study, we have sought to determine the
biophysical mechanisms by which membrane cholesterol
concentrations modulate M2AH activity. Given the myriad
of AH domain-containing proteins that regulate a range of
essential cellular processes, understanding the regulatory
mechanisms of AH domains and their intricate interplay with
membrane composition is of broad importance.
■ METHODS
All peptides were synthesized by Biomatik (Wilmington, DE,
USA) at 98% purity, with TFA removed. Peptide sequences
included N-terminal acylation, C-terminal amidation, and a
C50S mutation to prevent Cys oxidation. Sequences were as
follows: M2AH (47−62 of A/Udorn/72) Ac-FFKSIYRF-
FEHGLKRG-Am; M2AH-F47W Ac -WFKSIYRF-
FEHGLKRG-Am; M2AH-Y52W Ac -FFKSIWRF-
FEHGLKRG-Am; M2AH-F54W Ac -FFKSIYRW-
FEHGLKRG-Am. Fluorescent M2AH incorporates FITC
conjugated to K60, as previously reported.17,18 Lipids were




phosphocholine (6,7Br-POPC), and 1-palmitoyl-2-(11,12-
dibromo) stearoyl-sn-glycero-3-phosphocholine (11,12Br-
POPC) (Avanti Polar Lipids, Alabaster, AL, USA). Chloro-
form and deuterium oxide (D2O) were obtained from Sigma−
Aldrich (Dorset, U.K.).
Large Unilamellar Vesicles. Large unilamellar vesicles
(LUVs) were made by extrusion. Lipid solutions containing
12.5 μmol of lipids were made using a 4:1 molar ratio of
POPC:POPG and incorporating 0.5, 1, 15, or 30 mol % Ch, as
previously described.17,18 In brief, the lipid solution was dried
under a stream of argon gas, and residual chloroform was then
removed after storage for 1 h under vacuum. Lipid films were
then dissolved in 500 μL of potassium buffer (10 mM
K2HPO4, 50 mM K2SO4, 5 mM MOPS, pH 7.4), as previously
used for M2 structure and function studies,17,18 and hydrated
for 30 min at 5 °C above the phase transition temperature of
the lipid mix, with vortex mixing every 5 min. Lipid solutions
were then freeze-thawed 15 times, transferring between a dry
ice ethanol bath and a water bath at hydration temperatures
before extrusion using an Avanti Mini-Extruder, 26 times with
membranes with a pore size of 100 nm (Whatman Nuclepore
Track-Etched Membranes, GE Healthcare Bio-Sciences,
Pittsburgh, PA, USA) at hydration temperatures. LUVs were
stored at 4 °C and used within 1 week.
Fluorescence Polarization Anisotropy. 100 nM of
M2AH FITC labeled peptide was mixed increasing concen-
trations of POPC:POPG LUVs (0−50 μM) containing either
0.5, 15, or 30 mol % cholesterol in Greiner Bio-One 96-well,
black flat-bottomed plates. Fluorescence polarization aniso-
tropy was determined on the FLUOstart Omega fluorescent
plate reader (BMG Labtech, Bucks, U.K.), using a 482−16 nm
excitation filter and a 530−40 nm band-pass emission filter. All
data were blank-corrected before processing, and all experi-
ments were performed with six repeats. Data was analyzed with
GraphPad Prism 6 with Kd values determined by the least-
squares regression model and significant differences deter-
mined by Welch’s t-test of Kd.
Peptide Binding Assay. 100 μM of M2AH FITC labeled
peptide was mixed with 2.5 mM of the indicated lipid vesicles
and diluted with water to a final volume of 50 μL, as previously
described.18 Controls were made with 100 μM of M2AH
FITC-labeled peptide and water. Samples were incubated for 1
h at room temperature in darkness to allow for peptide-
membrane binding. After incubation, unbound peptide was
removed by washing twice through 100 kDa Amicon Ultra
centrifugal filters (Merck Millipore, Watford, U.K.). Retained
fluorescence was determined on the FLUOstart Omega
fluorescent plate reader, using a 492-nm excitation filter and
a 520-nm band-pass emission filter. All data were blank-
corrected before processing, and all experiments were
performed in triplicate.
Tryptophan−Bromine Quenching Assay. 50 μM of
F47W, Y52W, and F54W tryptophan-substituted M2AH
peptides were incubated for 1 h with 2.5 mM of LUVs
containing 0.5, 15, and 30 mol % cholesterol or with 2.5 mM of
LUVs containing bromine-labeled POPC at either the 6,7 or
11,12 positions and containing either 0.5, 15, and 30 mol %
cholesterol. The fluorescence emission spectra of the LUV
solutions were collected between 300 and 400 at 1 nm
intervals (λ excitation = 296 nm) in the presence and absence
of M2AH-W peptide and the background LUV-only
fluorescence was subtracted from the Typ fluorescence in the
presence of peptide. The depth of insertion of the Typ reside
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where ZCF is the distance of Typ residue from the center of the
bilayer, LC1 the distance between the 6,7 Br atom and the
bilayer center, and L21 the distance between the 6,7 Br atom
and the 11,12 Br atom. F1 is the Typ fluorescence intensity in
the presence of the 6,7 Br atom (λ emission = 338 nm), and F2
is the Typ fluorescence intensity in the presence of the 11,12
Br atom (λ emission = 338 nm). C is the two-dimension (2D)
concentration of Br atoms in the membrane plane (mole
fraction per unit area of Br-lipid/total lipid). Values for LC1
(10.8 Å), L21 (4.5 Å), and C (0.3/70 Å
2) have been previously
determined from X-ray diffraction (XRD) experiments.32,33
Laurdan Assay. 2.5 mM of LUVs were mixed with 25 μM
Laurdan dye (Life Technologies, Paisley, U.K.) and 200 μM of
peptide, where indicated, in a total volume of 50 μL, as
previously described.17 Fluorescence was measured on a Cary
Eclipse fluorescence spectrophotometer (Agilent Technolo-
gies, CA, USA) using a 355 nm excitation filter recording
fluorescence emissions at 440 and 490 nm. All experiments
were performed in triplicate. The Laurdan General Polarization







Molecular Dynamics Simulations. Peptide Model. The
three-dimensional (3D) structure of the α-helical Udorn M2
amphipathic helix (M2AH) peptide is taken from the NMR
ensemble and converted to CHARMM residue types. This
involves reassigning atom labels and making protonation states
consistent with predictions (ProPKA is used35); in particular,
lysines (residues 3 and 14) and arginines (residues 7 and 15)
have positively charged side chains (standard LYS and ARG
types), the glutamic acid (residue 10) has a negatively charged
side chain (GLU type), histidine (residue 11) has a neutral
side chain (HSE type). Standard N-terminal (NTERM,
−NH3+) and C-terminal (CTERM, −COO−) patches are
used. No further post-translational or chemical modifications
are applied.
System Setup. A single peptide per simulation box was
positioned by placing it parallel to the membrane plane and
translating it by 10, 15, 20, 25, or 30 Å, relative to the
Figure 1. Minimal effect of membrane cholesterol on M2AH binding and secondary structure. (A) FITC-labeled M2AH peptide was incubated
with increasing concentrations of LUVs containing 0.5, 15, or 30 mol % cholesterol and binding affinity was assessed by fluorescence polarization
anisotropy. Kd values were determined by the least-squares regression model (0.67 μM at 0.5% cholesterol, 1.51 μM at 15% cholesterol, and 3.87
μM at 30% cholesterol) and the significant difference in Kd between 0.5% and 30% LUVs was determined by Welch’s t-test of Kd (p = 0.0128). (B)
FITC-M2AH was incubated with LUVs for 1 h before fluorescence was determined. Values represent the vesicle-bound fluorescence/background
fluorescence and are means ± the standard deviation of three independent repeats. (C) MD simulation timeline of the helical secondary structure
for the POPC/POPG simulation M2AH_3. The color-coded letters have the following meanings: T, Turn; E, Extended (β sheet); B, Bridge; H, α
helix; G, 310-helix; I, PI-helix; and C, coil (none of the above). (D) Timeline of the helical secondary structure for the POPC/POPG/
CHLsimulation M2AH_CHL_3.
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membrane center (z = 0) in an orientation consistent with the
estimated (using HELIQUEST36) helical hydrophobic mo-
mentum vector, μ, which dictates the amphipathicity of the
helix.37 Physiological salt (150 mM KCl) is added to all
simulations by replacing randomly chosen water molecules
with K+ or Cl− ions. Two types of model lipid membranes are
investigated. The first is a POPC/POPG (80/20 component
ratio in both leaflets), and the second has cholesterol (CHL)
added, POPC/POPG/CHL (50/20/30 component ratio in
both leaflets). For more details, see the Supporting
Information.
Simulation Protocol. We use a standard simulation
protocol dictated by best practices: NPT ensemble (Nose−́
Hoover thermostat set to 300 K,38,39 semiisotropic Parrinello−
Rahman barostat set to 1 atm),40 LINCS constraints in H
atoms,41,42 2 fs integration time steps, particle-mesh Ewald
summation for electrostatic interactions,43 Force-switch
starting at 1.0 nm to a cutoff at 1.2 nm. The simulation time
is ∼300−600 ns per trajectory. We use the CHARMM-GUI44
membrane builder45,46 to initialize the geometries. GROMACS
(version 5.0)47 is used to perform the MD simulations,
CHARMM36 force field is used for the proteins48 and lipids49
with the TIP3P water model.50 VMD51 is used for analysis and
visualization. The recommended stepwise relaxation scheme,
which consists of minimization (step 6.0), equilibration (steps
6.1 through 6.6) before the production run, is started. Note
that the simulation temperature was chosen to match previous
biological experiments and, therefore, is not performed at
physiological temperature. However, the properties of our
model membranes are only weakly dependent on the
temperature within this range.52
Analysis Details. The helix angle is calculated by projecting
the directional vector from the α-C atom of Lys3 to His11
(exactly two helix turns away) onto the simulation box z-axis
vector. The penetration depth is monitored by following the z-
coordinate of residue Phe8. The secondary structure in the
peptide is monitored using the STRIDE algorithm.53 Salt
bridges are determined based on an O−N geometric bond
distance cutoff criterion of 3.2 Å. Hydrogen bonds are
determined based on a geometric bond distance cutoff of 3.0
Å and a bond angle cutoff of 20°. The packing analysis was
performed as previously described.54,55 In short, the area of the
lipid head groups was projected down to the gridded x/y plane,
and the points corresponding to hydrophobic defects were
Figure 2. Cholesterol modulates the M2AH depth of insertion. Molecular dynamics (MD) simulations of the M2AH peptide and different lipid
bilayers. (A) Side view of initial configurations chosen for the M2AH/bilayer simulations. Each starting position corresponds to a translation along
the z-axis, according to the values specified in panel (C). The M2AH peptides are otherwise positioned in the same orientation, with respect to the
bilayer membrane. (B) Representative penetration depth during simulation extracted from the peptide center of mass, relative to the membrane
center of mass. Trajectories M2AH_3 and M2AH_CHL_3 are shown, which are started at a z-axis offset of +2 nm. (C) Average peptide Z-location
from different starting configurations. Note that trajectories 4 and 5 did not bind consistently and are not used for analyses (indicated by an asterisk
(*)). (D) Representative snapshots of M2AH peptide in POPC:POPC bilayer simulations (from M2AH_3) and (E) POPC:POPG:cholesterol
bilayers (from M2AH_CHL_3). (F) 50 μM Y25W tryptophan-substituted M2AH peptide was incubated for 1 h with 2.5 mM LUVs containing 1,
15, and 30 mol % cholesterol and with cholesterol-varied LUVs containing bromine-labeled POPC at either the 6,7 or 11,12 positions. The
tryptophan fluorescence spectra were collected (Figure S2) and used to calculate the distance from the center of the membrane bilayer. Values are
shown as means ± standard deviation. No significant differences were observed between peptide insertion depth in 1 mol % cholesterol membranes
and 30 mol % membranes, with a Student’s t-test value of p = 0.69.
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clustered and measured to determine the size of the individual
clusters.
■ RESULTS
Minimal Effect of Membrane Cholesterol on M2AH
Binding and Secondary Structure. Previous results have
shown that the M2AH forms an helical structure upon
membrane binding.17 If cholesterol concentrations modulate
M2AH binding, this could directly impact domain formation
and the ability to alter membrane curvature. Thus, we first
determined the association of a FITC-tagged M2AH peptide
with POPC:POPG LUVs with a range of membrane
cholesterol concentrations, using fluorescence polarization
anisotropy. Liquid-disordered POPC:POPG membranes and
a nonpalmitoylated C50S M2AH peptide were specifically
chosen, because they represent a widely used model system for
evaluating the impact of cholesterol on M2AH structure and
function.2,17,18,26,27,30 We see that the affinity of M2AH
peptide binding to LUVs is slightly, but significantly, inversely
correlated with increasing cholesterol concentrations (Figure
1a), with calculated Kd values of 0.67 μM at 0.5% cholesterol,
1.51 μM at 15% cholesterol, and 3.87 μM at 30% cholesterol
(p-value, 0.5% vs 30%, is 0.0128). This is comparable to
previous work with other amphipathic peptides, where
cholesterol caused an overall increase in peptide binding but
a decrease in overall binding affinity.56 We also assessed
Figure 3. Cholesterol-dependent orientation of membrane-bound M2AH. (A) 50 μM F47W, Y52W, and F54W tryptophan-substituted M2AH
peptides were incubated for 1 h with 2.5 mM LUVs containing 0.5, 15, and 30 mol % cholesterol and with cholesterol-varied LUVs containing
bromine-labeled POPC at either the 6,7 or 11,12 positions. The tryptophan fluorescence spectra were collected and used to calculate the distance
from the center of the membrane bilayer. (B) MD simulation showing binned angles during the simulated trajectories (for trajectories 1−3). 90°
corresponds to the horizontal starting positions. (C) Binned roll angles during the simulated trajectories (for trajectories 1−3). (D) Peptide
orientations are shown in representative snapshots of the M2AH peptide in POPC:POPC bilayer simulations (M2AH_3) and (E)
POPC:POPG:cholesterol bilayers (M2AH_CHL_3).
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M2AH membrane binding by incubating FITC-M2AH peptide
with LUVs, removing unbound peptide by spin filtration and
quantifying the bound fluorescent signal. We see comparable
peptide binding to LUVs containing 5% and 30% cholesterol,
although binding is slightly increased at 10% (see Figure 1b).
To determine if cholesterol affects M2AH α-helix secondary
structure formation, we attempted to determine the NMR
structure of the M2AH bound to high- and low-cholesterol
LUV membranes. Our previous results have determined the
low-cholesterol NMR structure of the M2AH;17 however,
when bound to 30% cholesterol LUVs, the peptide-transferred
NOE NMR signal is lost, suggesting possible changes in
M2AH Koff rates, although these were not assessed in this
study. Instead, we have used all-atom molecular dynamics
(MD) simulations to investigate modeled M2AH secondary
structure changes over time on POPC:POPG bilayers,
compared to POPC:POPG bilayers containing 30% cholesterol
(see Figure S1 in the Supporting Information). Our results
show that M2AH forms a stable α-helix secondary structure
under both membrane conditions, in a manner similar to that
observed in previously reported results with other amphipathic
peptides,56 although there seems to be more structural
fluctuations and flexibility of the M2 α-helix in the absence
of cholesterol (Figure 1c and 1d). Together, these results
suggest that the ability of cholesterol to modulate M2AH
activity is not strongly affected by differential membrane
binding or the induction of a secondary structure.
Membrane Cholesterol Alters the Depth and Angle
of M2AH-Membrane Insertion. While cholesterol may not
strongly impact M2AH-membrane binding, cholesterol may
modulate the orientation of the peptide within the membrane,
with subsequent effects on activity. In order to estimate the
depth of M2AH membrane insertion and the effect of
membrane cholesterol, we first performed MD simulations,
examining the behavior of the modeled peptide on
POPC:POPG bilayers, compared to POPC:POPG bilayers
containing 30% cholesterol. Analysis of multiple repeated
simulations showed that the M2AH peptide was more
frequently found slightly deeper within the membrane (toward
the bilayer midplane) when 30% cholesterol was present (see
Figures 2a−e). These results were further examined by using
tryptophan (Typ) fluorescence quenching by bromine-labeled
lipids to determine the depth of peptide insertion in the
membrane. The M2AH peptide was substituted with Y52W to
enable Typ fluorescence measurements. Typ fluorescence is
sensitive to the presence of bromine, thus lipids with Br
conjugated to the 6−7 lipid tail position, the 9−10 position, or
the 11−12 position were used to estimate the depth of M2AH
insertion. For reference, Br-6,7 conjugated lipids will quench
Typ fluorescence when it is below the level of the lipid
headgroups but not when it is at the level of the headgroups or
on the surface of the membrane. The M2AH-Y52W peptide
was added to LUVs containing Br-6,7-PC or Br-11,12-PC with
1%, 15%, or 30% cholesterol, the Typ fluorescence spectra
were collected (see Figure S2 in the Supporting Information)
and used to calculate the distance of the Typ residue from the
bilayer center, using the modified parallax equation.57 These
results also showed a slight, but nonstatistically significant,
difference in membrane penetration depth, suggesting that
membrane cholesterol levels do not significantly alter M2AH Z
positioning in the membrane (see Figure 2f).
To examine if cholesterol affects the angle of the peptide
within the membrane, we expanded our Typ quenching
experiments by using M2AH peptides with Typ substitutions
at different points along the length of the helix. Using our
previous saturation transfer difference NMR experiments as a
guide for peptide−membrane interactions, we selected three
bulky hydrophobic residues that would likely be compatible
with Typ substitutions without affecting membrane binding or
secondary structure.17 The M2AH peptide was substituted
with either F47W, Y52W, or F54W, and each different M2AH-
W peptide was added to LUVs containing Br-6,7-PC or Br-
11,12-PC with 1%, 15%, or 30% cholesterol; the Typ
fluorescence spectra were collected (Figure S2) and used to
calculate the distance of the Typ residue from the bilayer
center. As with the Y52W substitution, we did not detect a
difference between the average depth of the W47 or W54
residues (see Figure 3a). However, N-terminal residues (e.g.,
W47) of the peptide showed increased depth in the membrane
at low-cholesterol concentrations, compared to C-terminal
residues, whereas at high cholesterol concentrations, all
residues showed comparable depths (Figure 3a). This suggests
that cholesterol may affect the orientation of M2AH in the
membrane. These results are supported by the MD
simulations, which showed that M2AH was most frequently
found oriented at ∼92° from the bilayer normal (inclination in
the Z-axis) in the absence of cholesterol, but at ∼98°, in the
presence of cholesterol (see Figures 3b, 3d, and 3e). In
addition, the presence of cholesterol causes a ∼10° counter-
clockwise rotation of the helix within the membrane (Figure
3c). Together, these results show that cholesterol affects the
positioning of the M2AH within the membrane. The key
amino acid residue of M2AH in most-frequent direct contact
with cholesterol was identified in the MD simulations as F54,
which inserts deeply into the membrane (see Figure S3a in the
Supporting Information). Because of the secondary helical
structure of the peptide, residues that are four positions
upstream and downstream (C50 and G58/L59, respectively)
also showed increased contact with cholesterol (see Figure
S3a). No stereospecific interactions between M2AH and
cholesterol were observed. Furthermore, the cholesterol
hydroxyl group does not appear to form a stable hydrogen
bond to the peptide (including its backbone) and, as such,
likely has little influence on the peptide structure. Instead, the
dominant interaction between M2AH and cholesterol is found
to be a hydrophobic stacking interaction between F54 and the
hydrocarbon rings of cholesterol (see Figure S3b in the
Supporting Information). Per-residue contacts between M2AH
and POPC/POPG lipids were quantified in the presence and
absence of cholesterol, with only minor differences being
observed (see Figures S3c and S3d in te Supporting
Information). Interactions between counterions and the
phospholipids were also examined, with counterions coordi-
nating closer around the phospholipids in the presence of
cholesterol, especially with POPG (Figures S3e and S3f in the
Supporting Information). This suggests that cholesterol affects
the positioning of M2AH, which may then affect the
positioning of the lipid headgroups.
Cholesterol Limits M2AH-Induced Lipid Headgroup
Separation Required for Curvature and Membrane
Scission. Changes in AH domain membrane insertion can
have significant impacts on lipid headgroup separation and
affect the ability to alter membrane curvature and cause
scission. To assess the effects of cholesterol on M2AH’s ability
to alter lipid headgroup separation, we used MD simulation to
assess the likelihood of given distances of separation between
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lipid headgroup P atoms (PC−PC, PC−PG, or PG−PG) in
the presence and absence of cholesterol. The results show that,
while M2AH induces minimal changes in the separation
between PC−PC and PC−PG headgroups, M2AH causes a
decrease in PG−PG P atom distances in the presence of 30%
cholesterol, but no change in distances in the absence of
cholesterol (Figure 4a). The differential effect on PG instead of
PC may be attributed to the strong interaction of the cationic
surface of the M2AH with charged anionic lipids such as PG.17
Interestingly, the presence of cholesterol itself caused a
separation of PG headgroups (Figure 4a), and it is possible
that this separation increases lipid phase separation while the
ability of M2AH to cluster PG headgroups mitigates this effect,
slightly reducing the strain on the membrane in the presence of
30% cholesterol and reducing M2AH scission activity.
M2AH-induced changes in lipid packing may further affect
the ability of the domain to induce lipid ordering. As lipid
ordering has been shown to affect line tension and membrane
scission, alterations of M2AH-induced lipid ordering could
have significant impacts on virus budding.17 To investigate if
cholesterol alters M2AH induction of lipid ordering, we added
M2AH peptide to Laurdan-labeled LUVs and assessed changes
in the GP function of the dye. Laurdan is a hydrophobic dye
that incorporates into the lipid bilayer at the lipid tails and
undergoes emission spectrum shifts based on the exposure of
the dye to polar media; therefore increases in Laurdan GP
indicate a decrease in exposure of the dye to the aqueous
environment caused by an increase in lipid order and lipid
packing. We see that the addition of the M2AH peptide to
Laurdan-containing LUVs causes a statistically significant
increase in lipid order in low-cholesterol LUV (Figure 4b).
However, in the presence of 30% cholesterol, the M2AH
peptide is no longer able to alter lipid order, suggesting that
orientation of the peptide in the membrane may affect lipid
packing and, thus, modulate M2AH activity.
■ DISCUSSION AND CONCLUSIONS
The M2AH is a membrane-active domain that has been shown
to bind membranes and alter curvature in a cholesterol-
dependent process that is essential for membrane scission and
the release of budding influenza virions.2,12,13 Cholesterol has
been previously shown to bind to the M2 protein at multiple
sites,26 including residues F47, F54, and R61 of the AH
domain.27 In high levels of membrane cholesterol (>20%),
M2AH loses its ability to alter membrane curvature and cause
scission in vesicle models,2 although the specific biological
effect of cholesterol on M2AH activity remains unclear. In this
study, we have investigated the effect of cholesterol on the
ability of the M2AH to associate with and modify model
membranes.
The M2AH binds to a variety of biological membranes and
is structured into an α-helix only upon membrane binding.17
Here we show that the presence of 30% cholesterol, in LUV
membranes, has minimal impact on M2AH membrane binding
(Figures 1a and 1b) and slightly increases the speed of α-helix
formation upon membrane contact (Figures 1c and 1d). These
results agree with previous ssNMR experiments that showed
comparable α-helix formation and association of the AH
domain with membranes of increasing cholesterol concen-
tration.28,29 This suggests that cholesterol does not strongly
affect M2AH binding or secondary structure formation, though
the helix was found to be more stable28 and more tightly
packed in the presence of cholesterol.29 It is possible this
change in M2AH packing density would affect protein
clustering, increasing the “effective” local concentration in
the membrane and inducing membrane curvature, as has been
previously shown through ssNMR and MD simulations with
the full-length M2 protein,11,58 although the direct effects of
cholesterol on M2 clustering have yet to be proven.
While cholesterol does not affect membrane binding by
M2AH, it may slightly affect the depth of membrane insertion
of the domain and significantly alter its orientation within the
membrane. MD modeling and Typ bromine quenching
experiments show that the M2AH is inserted at a comparable
or slightly deeper depth in the membrane in the presence of
cholesterol (see Figure 2), this contrasts with previous ssNMR
studies that showed the AH domain is somewhat less buried in
the membrane in the presence of cholesterol.29 However, the
ssNMR experiments were performed with a M2 TMD-AH
construct and it is likely that the presence of the TMD affects
the depth of AH membrane insertion. The study also found
Figure 4. Cholesterol modulates the ability of M2AH to induce lipid
order. (A) MD simulation RDFs of P atom pair distributions between
POPC−POPC (top), POPC−POPG (middle), and POPG−POPG
(bottom). Results are averaged over trajectories 1−3. (B) 2.5 mM
LUVs containing 5, 10, 20, or 30 mol % cholesterol were incubated
for 1 h with 25 μM Laurdan dye in the presence or absence of
increasing amounts of M2AH peptide. Laurdan fluorescence was then
measured at 440 and 490 nm, and the ratio was used to calculate the
Laurdan GP. Values are shown as GP(M2AH-LUVs) − GP(LUVs)
and are the mean ± standard deviation of three independent repeats.
Asterisk symbol (*) indicates a statistically significant change in GP
upon peptide insertion, with a Student’s t test value of p < 0.05. No
significant change in GP was seen with 30% cholesterol LUVs, p =
0.996.
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that cholesterol changed the angle and rotation of the helix
within the membrane.29 Our results confirm and expand these
observations by demonstrating cholesterol-induced changes in
the angle and rotation of the helix, relative to the bilayer
normal. At high levels of membrane cholesterol, the AH is
oriented parallel to the membrane, whereas in low levels of
cholesterol, the M2AH undergoes a ∼6° tilt and is now angled
in the membrane, along with a ∼10° rotation of the helix that
may change the ability of the M2AH to modify membrane
properties (Figure 3). AH domains inserted in the membrane
are known to have different biological effects that are
dependent on the helix orientation in the membrane. Many
cell-penetrating antimicrobial peptides alter membrane curva-
ture: at low concentrations, they bind parallel to the
membrane, and at high concentrations, these peptides often
change their orientation in the membrane, so that the helix is
now perpendicular to the membrane and can form pores.59
While the effect of concentration on the M2AH membrane
orientation has never been assessed, the ∼6° change in angle of
the M2AH (Figure 3) does not appear to be sufficient to form
pores in the membrane. However, the M2AH can cause
membrane leakage in vesicles and the range of biological
activity of the M2AH, from leakage to curvature and scission,
may be dependent on peptide orientation in the mem-
brane.2,29,58
Here, our results show that cholesterol alters the orientation
of the M2AH peptide, which then mediates different
biophysical effects on the membrane. In low-cholesterol
membranes, insertion of the angled M2AH peptide causes
changes in lipid tail packing that result in increased lipid
order,17 and likely increase membrane line tension11 (Figure
4b). In contrast, in high levels of cholesterol, modeling
suggests that there is increased separation of anionic lipid
headgroups. In this environment, the membrane-parallel
insertion of the M2AH peptide reduces headgroup separation
and does not affect lipid order (Figures 4a and 4b). It is
possible that M2AH cannot further increase lipid order beyond
the contribution of 30% cholesterol, which is known to
increase lipid order.60 High membrane cholesterol levels, and
the associated lipid headgroup separation,60 may also enable
peptide binding without disruption of membrane structure, as
has been shown for other AH-containing antimicrobial
peptides.56
M2 has been shown to cluster and mediate membrane
scission at lipid phase boundaries, acting as a linactant and
likely using the line tension energy between the lipid phases to
drive membrane scission.2,11,58,61 Recent results have validated
these predictions by showing that increasing membrane stress
facilitates M2 induction of membrane curvature.11 Thus,
alteration of either lipid headgroup separation or lipid order
and membrane tension can be sufficient to alter membrane
curvature and cause scission, thus suggesting a mechanism
action for the M2AH.62−64 However, given that cholesterol can
be an organizing factor in lipid raft formation, which would
increase local membrane tension, it is rather surprising that, in
lipid vesicle systems, high levels of membrane cholesterol
inhibit scission activity, instead of promoting activity.2 It is
possible that this discrepancy is dependent on the activity of
cholesterol in different membrane model systems. In single
lipid phases, cholesterol increases lipid mixing and decreases
the size of lipid nanodomains, effectively reducing nanodomain
line tension, whereas with lipid mixtures that can phase
separate, increasing cholesterol in the gel phase beyond 16%
causes the formation of Lo phases.65 Thus, cholesterol may
both affect the orientation of the M2AH domain in the
membrane and affect membrane tension levels (which M2AH
uses to drive membrane scission), with differential effects of
cholesterol in single lipid phases, phase-separated lipids, and in
biological membranes with structured lipid domains. Further
research is necessary to determine the specific impact of
cholesterol on M2AH orientation and function in these
different biological membranes.
In the context of the full-length M2 protein, the AH domain
is but one membrane-active region. It has been shown that the
TMD also possesses curvature-altering abilities and the AH
domain is more effective in the full-length protein,12 possibly
because the native tetramer form of the protein enhances the
effective concentration of the AH domain, or because the
anchoring of one end of the AH affects the subsequent angle of
membrane insertion and, thus, biological activity. Further work
is needed in order to determine how the structure of the AH
domain is affected by its N-terminal anchoring to the TMD
and how cholesterol modifies domain orientation and function
in the context of the full-length protein. All of these
components are inter-related, and a full understanding of
M2-mediated scission will be required to understand the sum
of the parts. Here, our data suggest that cholesterol modifies
M2-mediated membrane scission by altering the angle and
depth of helix membrane insertion, affecting the formation of
lipid packing defects and the induction of line tension between
lipid phases. This may allow for spatial-temporal control over
the budding process, balancing M1 interactions during
assembly with the mediation of scission during virus release.28
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